Rifampin 600 mg

DRUG4 trials

Sponsors

Eisai Inc., University of Colorado, Denver, Eisai Co., Ltd., Hutchmed

Conditions

ContraceptionHealthy ParticipantsHealthy SubjectsRelapsed or Refractory LymphomaTuberculosis

Phase 1

A 2-Part Study to Assess Potential Metabolism-Based Drug-Drug Interactions of E2006 When Coadministered With Itraconazole, Rifampin, Midazolam, or Bupropion

CompletedNCT02085967

Eisai Inc.Healthy Subjects

Start: 2014-02-28End: 2014-06-30Updated: 2015-11-03

A Study to Assess the Effect of Food Intake and Drug-drug Interactions of E7090 When Co-administered With Rabeprazole or Rifampin in Healthy Participants

CompletedNCT04565574

Eisai Co., Ltd.Healthy Participants

Start: 2020-10-16End: 2021-03-31Updated: 2021-11-01

HMPL-689 Drug Interaction Study With CYP3A Inhibitor/CYP2C9 Inhibitor/CYP3A Inducer/PPI

CompletedNCT05602597

HutchmedRelapsed or Refractory Lymphoma

Start: 2022-06-01End: 2022-08-06Updated: 2024-03-06

Phase 4

Rifampin and the Contraceptive Implant

CompletedNCT04463680

University of Colorado, DenverContraception, Tuberculosis

Start: 2020-09-23End: 2022-02-22Updated: 2023-05-16